- €3.01bn
- €563.44m
- €555.54m
- 51
- 23
- 62
- 38
Annual income statement for Allfunds, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,589 | 2,669 | 2,742 | 492 | 556 |
Cost of Revenue | |||||
Gross Profit | 309 | 506 | 495 | 469 | 530 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,572 | 2,584 | 2,654 | 400 | 701 |
Operating Profit | 17.8 | 85 | 88.1 | 91.8 | -145 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 15.2 | 75.4 | 83.7 | 153 | -70.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.043 | 108 | 49.2 | 85.7 | -169 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.043 | 108 | 49.2 | 85.7 | -169 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.043 | 108 | 49.2 | 85.7 | -169 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.002 | 0.179 | 0.092 | 0.143 | 0.005 |
Dividends per Share |